118 related articles for article (PubMed ID: 36637040)
1. Perilla seed oil improves bone health by inhibiting bone resorption in healthy Japanese adults: A 12-month, randomized, double-blind, placebo-controlled trial.
Matsuzaki K; Hossain S; Wakatsuki H; Tanabe Y; Ohno M; Kato S; Shido O; Hashimoto M
Phytother Res; 2023 Jun; 37(6):2230-2241. PubMed ID: 36637040
[TBL] [Abstract][Full Text] [Related]
2. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
[TBL] [Abstract][Full Text] [Related]
3.
Hashimoto M; Matsuzaki K; Maruyama K; Hossain S; Sumiyoshi E; Wakatsuki H; Kato S; Ohno M; Tanabe Y; Kuroda Y; Yamaguchi S; Kajima K; Ohizumi Y; Shido O
Food Funct; 2022 Mar; 13(5):2768-2781. PubMed ID: 35171190
[No Abstract] [Full Text] [Related]
4. Effects of marine-derived and plant-derived omega-3 polyunsaturated fatty acids on erythrocyte fatty acid composition in type 2 diabetic patients.
Liu H; Wang F; Liu X; Xie Y; Xia H; Wang S; Sun G
Lipids Health Dis; 2022 Feb; 21(1):20. PubMed ID: 35144649
[TBL] [Abstract][Full Text] [Related]
5.
Hashimoto M; Matsuzaki K; Maruyama K; Sumiyoshi E; Hossain S; Wakatsuki H; Kato S; Ohno M; Tanabe Y; Kuroda Y; Yamaguchi S; Kajima K; Ohizumi Y; Shido O
Food Funct; 2022 Jul; 13(13):7226-7239. PubMed ID: 35722977
[TBL] [Abstract][Full Text] [Related]
6.
Hashimoto M; Matsuzaki K; Hossain S; Ito T; Wakatsuki H; Tanabe Y; Ohno M; Kato S; Yamashita K; Shido O
Foods; 2021 May; 10(5):. PubMed ID: 34069601
[TBL] [Abstract][Full Text] [Related]
7. The opposite effects of Antarctic krill oil and arachidonic acid-rich oil on bone resorption in ovariectomized mice.
Zhan Q; Tian Y; Han L; Wang K; Wang J; Xue C
Food Funct; 2020 Aug; 11(8):7048-7060. PubMed ID: 32813003
[TBL] [Abstract][Full Text] [Related]
8. Twelve-month Studies on
Hashimoto M; Matsuzaki K; Kato S; Hossain S; Ohno M; Shido O
Foods; 2020 Apr; 9(4):. PubMed ID: 32331363
[No Abstract] [Full Text] [Related]
9. Altered levels of BMD, PRL, BAP and TRACP-5b in male chronic patients with schizophrenia.
Du X; Ye F; Li J; Zhao Y; Xiao W; Tang X; Zhang X
Sci Rep; 2020 Aug; 10(1):13598. PubMed ID: 32788631
[TBL] [Abstract][Full Text] [Related]
10. Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.
Mokhtar GM; Tantawy AA; Hamed AA; Adly AA; Ismail EA; Makkeyah SM
Clin Appl Thromb Hemost; 2017 Jan; 23(1):64-71. PubMed ID: 26149452
[TBL] [Abstract][Full Text] [Related]
11. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
[TBL] [Abstract][Full Text] [Related]
12. Reference values for bone metabolism in a Japanese cohort survey randomly sampled from a basic elderly resident registry.
Tokida R; Uehara M; Nakano M; Suzuki T; Sakai N; Ikegami S; Takahashi J; Nakamura Y; Kato H
Sci Rep; 2021 Apr; 11(1):7822. PubMed ID: 33837266
[TBL] [Abstract][Full Text] [Related]
13. Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.
Välimäki MJ; Farrerons-Minguella J; Halse J; Kröger H; Maroni M; Mulder H; Muñoz-Torres M; Sääf M; Snorre Øfjord E
Clin Ther; 2007 Sep; 29(9):1937-49. PubMed ID: 18035193
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic Acid.
Kasai H; Mori Y; Ose A; Shiraki M; Tanigawara Y
J Clin Pharmacol; 2021 May; 61(5):606-613. PubMed ID: 33135182
[TBL] [Abstract][Full Text] [Related]
15. Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol.
Nakatoh S
J Bone Miner Metab; 2018 Mar; 36(2):221-228. PubMed ID: 28293779
[TBL] [Abstract][Full Text] [Related]
16. Cholecalciferol Supplementation Promotes Bone Turnover in Chinese Adults with Vitamin D Deficiency.
Yao P; Sun L; Xiong Q; Xu X; Li H; Lin X
J Nutr; 2018 May; 148(5):746-751. PubMed ID: 29897564
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
Chen CJ; Chao TY; Janckila AJ; Cheng SN; Ku CH; Chu DM
J Pediatr Endocrinol Metab; 2005 Jan; 18(1):55-62. PubMed ID: 15679069
[TBL] [Abstract][Full Text] [Related]
18. Intake of Alpha-Linolenic Acid-Rich
Hashimoto M; Tanabe Y; Hossain S; Matsuzaki K; Ohno M; Kato S; Katakura M; Shido O
Molecules; 2020 Apr; 25(9):. PubMed ID: 32365849
[TBL] [Abstract][Full Text] [Related]
19. Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption.
Sølling AS; Harsløf T; Jørgensen NR; Langdahl B
Osteoporos Int; 2023 Mar; 34(3):599-605. PubMed ID: 36543965
[TBL] [Abstract][Full Text] [Related]
20. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
Nenonen A; Cheng S; Ivaska KK; Alatalo SL; Lehtimäki T; Schmidt-Gayk H; Uusi-Rasi K; Heinonen A; Kannus P; Sievänen H; Vuori I; Väänänen HK; Halleen JM
J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
